Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Evofem Biosciences, Inc.

OTC: EVFM · Life Sciences · 4 alerts · CIK 1618835

Share price
$0.0060Close, Nov 13
Market cap
$795K
Shares outstanding
132.53MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Evofem Biosciences, Inc. filings on SEC EDGAR ↗

4:06 PM ET 8-K
Loan & Debt

Evofem Biosciences Debt Financing Update with Adjuvant Global Health Technology Fund, L.P.

Evofem Biosciences entered into a fifth amendment to its Securities Purchase Agreement with Adjuvant Global Health Technology Fund. The amendment extends the maturity date of outstanding convertible promissory notes to December 1, 2026, and removes certain affirmative covenants.

Counterparty
Adjuvant Global Health Technology Fund, L.P.
Term
through Dec 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.